PFE (112, 33%), percutaneous retrogasserian glycerol rhizotomy (107, 31%), and balloon microcompression (two, 1%). Adult patients less than 70 years old in whom I performed primary surgery for idiopathic TN between July 1999 and March 2004 were eligible for enrollment in this study. Every patient had persistent pain despite medical therapy, and each one suffered episodic shocklike pain within the trigeminal distribution. Patients were informed that PFE was the surgery most likely to relieve their pain without causing facial numbness. Despite this information, 28 patients opted for SRS, whereas 55 underwent PFE; the patient characteristics are outlined in Table 1 . Patients who underwent SRS were older than the ones in the PFE group (60.5 compared with 50.7 years, p Ͻ 0.001). The groups were otherwise similar with regard to sex, pain duration, pain location, and presence of constant pain.
Specific operative details for the two procedures are as previously described. 19, 23 During PFE, the superior cerebellar artery compressed the trigeminal nerve alone or in conjunction with other vessels in 44 cases (80%), the anterior inferior cerebellar artery in two cases (4%), and the basilar artery in one case (2%). Venous compression was noted in four cases (7%). In six patients (11%), partial nerve section was performed either alone (four cases) or in conjunction with MVD (two cases). Of note, three (38%) of eight patients with some degree of constant facial pain underwent partial nerve section compared with three (6%) of 47 patients who described no constant face pain before surgery (p = 0.03). The mean hospital duration of stay was 3.1 days. Stereotactic radiosurgery was performed using the Gamma Knife unit (Elekta Instruments, Norcross, GA). All patients were treated with a single 4-mm isocenter of radiation directed at the root entry zone. The mean maximum radiation dose delivered to the trigeminal nerve was 89.1 Gy (range 85-97.9 Gy; doses corrected to an output factor of 0.87 Gy). All patients who underwent SRS were discharged on the day of the procedure.
Preoperative, surgical, and postoperative follow-up information was entered into a prospectively maintained database. Patients were contacted 3 months postsurgery, and then yearly thereafter to assess their facial pain outcome. Facial pain outcomes were classified as excellent (absence of lancinating facial pain without medications for TN), good (complete pain relief but still requiring a low dose of medications), fair (continued facial pain but reduced Ͼ 50% compared with before surgery), and poor. Patient follow-up data were censored at last contact (65 patients), time of subsequent surgery (17) , or death (one). The mean follow-up duration was 25.5 months.
Kaplan-Meier curves were calculated to determine the percentage of patients achieving and maintaining an excellent facial pain outcome after surgery. 12 Differences in facial pain outcomes between the surgical groups were tested by log-rank methods. Univariate comparisons of continuous variables were compared using the Student t-test; proportional differences were compared by the Fisher exact test.
RESULTS
Initial pain results after PFE were excellent in 49 patients (89%), and good, fair, and poor in two patients each (4%). In 12 patients (22%) recurrent pain developed at a median interval of 3 months postsurgery. At the last follow-up visit, 39 patients (71%) were pain free without medications. Excellent facial pain outcomes were achieved and maintained in 75 and 72% of patients at 1-and 3-year intervals, respectively, after PFE.
Initial pain results after SRS were excellent in 16 patients (57%), good in five (18%), fair in three (11%), and poor in four (14%). Three patients (11%) had pain recurrence at a median of 4 months postsurgery. At the last follow-up visit, 15 patients (54%) were free of pain without medications. Excellent facial pain outcomes were achieved and maintained in 59% of patients at 1-and 3-year intervals after SRS. These results show that patients who underwent PFE were more likely to achieve and maintain an excellent facial pain outcome compared with the stereotactically treated group (p = 0.01; Fig. 1 ). There was no significant difference in the number of patients who underwent additional surgery after PFE (10 patients) and SRS (eight) (18% compared with 29%, p = 0.4).
Complications after PFE included cerebrospinal fluid leakage that required repair (two patients), wound infection (one), and symptomatic transverse sinus thrombosis requir- ing optic nerve fenestrations (one). Eight patients (15%) had either new facial numbness (six cases) or dysesthesias (two cases) postsurgery. Excluding the six patients who underwent partial nerve section, the chance of new numbness after MVD was 4%. No treatment-related complications occurred after SRS, although 12 patients (43%) had either new facial numbness (nine cases) or dysesthesias (three cases) after radiosurgery. The incidence of new trigeminal deficits by maximum radiation dose was two (50%) of four for 85 Gy, six (33%) of 18 for 87 Gy, and four (67%) of six for 97.9 Gy. No correlation was found between trigeminal deficits after PFE and excellent facial pain outcomes (p = 0.37), whereas new trigeminal deficits did correlate with excellent facial pain outcomes after SRS (p = 0.02).
DISCUSSION
The goal of surgery for TN is to eliminate the patient's facial pain with minimal morbidity. In this series, PFE provided a significantly higher cure rate than SRS in patients with previously nonsurgically treated idiopathic TN. This is noteworthy because the patients in the radiosurgery group would be predicted to do better than those in published reports on radiosurgery for TN (Table 2) for several reasons. First, patients in this comparison had not undergone prior surgeries for their facial pain. In several reports investigators have shown that patients who experience recurrent pain after their initial surgeries have worse results after SRS than patients who have not undergone prior surgical treatment. 17, 23 Second, the mean radiation dose used over this time frame was rather high (89.1 Gy). At radiation doses below 80 Gy, the chance of remaining pain free without medications 3 years after SRS is 40% or less. 5, 17 Conversely, at radiation doses above 85 Gy, approximately 55 to 60% of patients are pain free without medications 3 years after treatment. 18, 22 Most centers, however, have gradually reduced the radiation dose to minimize the chance of bothersome facial numbness after SRS. 22 Therefore, the results of this study contradict the claim by some radiosurgery centers that SRS provides equivalent facial pain outcomes compared with PFE and should be considered the primary surgical option for patients with medically unresponsive TN.
The majority (89%) of patients in whom a PFE was performed underwent MVD. This procedure is nondestructive and removes the neurovascular compression believed to be the origin of facial pain for the majority of patients with TN. Unlike ablative techniques, pain relief after MVD is independent of postoperative facial sensory disturbances. 3, 4 Moreover, the pain relief after MVD has also been determined to be quite durable. In the large series by Barker, et al., 3 on 1185 patients, 70% of patients were free of pain without medications for TN 10 years postoperatively. Likewise, Tronnier, et al., 29 found excellent outcomes in 65% of patients 10 years after MVD. Thus, if the goals of TN surgery are elimination of facial pain without medications and preservation of trigeminal function, then MVD is the best available operation.
Nevertheless, in some patients no neurovascular compression is found at surgery. The ability to perform a partial nerve section provides another means to provide pain relief, but most patients will experience a degree of facial numbness if the nerve is cut or intentionally manipulated. 14, 24 The obvious drawback of PFE is the potential risk associated with this operation. Nonetheless, the chance of major morbidity or death after PFE is low. In my series, only one patient (2%) suffered a new neurological deficit other than facial numbness.
Despite these considerations, PFE may not be the best operation for all patients. Negative predictive factors after MVD include female sex, long pain duration, prior MVD, and atypical pain features. 2, 28, 30 Of note, in this series 15% of the patients who underwent a PFE described a component of constant facial pain in addition to intermittent shocklike pains. A neurovascular conflict was frequently not detected at surgery in patients with constant facial pain, and these individuals more frequently underwent a partial nerve section rather than an MVD. Although it is likely that these patients have Type 2 TN based on Burchiel's 7 recent facial pain classification scheme, I avoided using this terminology because it would disrupt the prospective nature of the TN patient database.
Importantly, age has not been correlated with worse outcomes after MVD for TN. Investigators in several papers have concluded that outcomes for MVD in patients older than 65 years were similar to those in younger patients, with no increase in the risk of serious morbidity or death. 11, 20, 25 Thus, MVD appears to be safe and effective even for older patients with TN if their general medical condition is stable and the aim of treatment is complete pain relief without medications. Finally, PFE is predicted to be a more costeffective option than SRS, despite higher procedural costs, because of its increased efficacy and the less frequent need for later surgeries. 21 At our center, the cost of a qualityadjusted pain-free year after PFE was $8174 compared with $8269 for SRS. 
